Search

Your search keyword '"Nokihara H"' showing total 15 results

Search Constraints

Start Over You searched for: Author "Nokihara H" Remove constraint Author: "Nokihara H" Publisher wiley publishing on behalf of the japanese cancer association Remove constraint Publisher: wiley publishing on behalf of the japanese cancer association
15 results on '"Nokihara H"'

Search Results

1. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.

2. S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.

3. Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.

4. Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancer.

5. Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.

6. Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

7. Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism.

8. Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer.

9. Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor.

10. A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors.

11. Innovator and generic cisplatin formulations: comparison of renal toxicity.

12. Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

13. Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity.

14. Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.

15. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules.

Catalog

Books, media, physical & digital resources